首页|美罗培南联合血必净注射液治疗重症肺炎患者的疗效及对炎症因子的影响

美罗培南联合血必净注射液治疗重症肺炎患者的疗效及对炎症因子的影响

扫码查看
目的 探讨美罗培南联合血必净注射液治疗重症肺炎患者的疗效及对炎症因子的影响.方法 选取 2020 年 3 月~2023 年 5 月诊治的重症肺炎患者 60 例,采用随机数字表法将其分为两组.对照组(30 例)采用美罗培南治疗,观察组(30 例)采用美罗培南联合血必净注射液治疗,对比两组患者治疗效果、炎症水平[血清C反应蛋白(CRP)、降钙素原(PCT)水平]、血气指标情况[氧分压(PaO2)、二氧化碳分压(PaCO2)、血氧饱和度(SpO2)]和临床观察指标.结果 观察组治疗有效率 90.00%(27/30)高于对照组 66.67%(20/30),差异有统计学意义(P<0.05);治疗后,观察组炎症因子CRP、PCT水平低于对照组,差异有统计学意义(P<0.05);治疗后,观察组血气指标PaO2、SpO2 水平高于对照组,PaCO2 水平低于对照组,差异有统计学意义(P<0.05);治疗后,观察组肺部啰音消失时间、退热时间、有创机械通气/无创机械通气的使用时间、ICU病房住院时间均低于对照组,差异有统计学意义(P<0.05).结论 重症肺炎患者采用血必净注射液联合美罗培南治疗可以有效降低机体内的炎症水平,从而提高血气指标,促进肺功能的恢复,加快患者的脱机,缩短患者ICU病房住院时间,具有较好的临床效果.
Curative effect of Xuebijing Injection combined with meropenem on patients with severe pneumonia and its influence on inflammatory factors
Objective To investigate the curative effect of Xuebijing Injection combined with meropenem in the treatment of severe pneumonia and the effect on inflammatory factors.Methods Sixty patients with severe pneumonia diagnosed and treated from March 2020 to May 2023 were selected and divided into two groups by random number table method.The control group(30 cases)was treated with meropenem,the observation group(30 cases)was treated with Xuebijing Injection combined with meropenem.The treatment effect,inflammation level[serum C-reactive protein(CRP),procalcitonin(PCT)level],blood gas index[partial pressure of oxygen(PaO2),partial pressure of carbon dioxide(PaCO2),blood oxygen saturation(SpO2)]and symptom resolution time were compared between the two groups.Results The effective rate of the observation group was 90.00%(27/30)higher than that of the control group 66.67%(20/30),a statistically significant difference was observed(P<0.05);Following treatment,the levels of inflammatory factors CRP、PCT in the observation group were lower than those in the control group,with statistically significant difference(P<0.05);Following treatment,compared with the control group,the blood gas index PaO2 and SpO2 levels in the observation group were higher,and PaCO2 was lower,with statistically significant difference(P<0.05);Following treatment,the absence time of lung rales,fever reduction time,invasive mechanical ventilation/non-invasive mechanical ventilation use time and ICU stay time in the observation group were lower than those in the control group,with statistically significant difference(P<0.05).Conclusion In patients with severe pneumonia,the treatment of Xuebijing Injection combined with meropenem can effectively reduce the level of inflammation in the body,improve the blood gas index,promote the recovery of lung function,accelerate the offline of patients,shorten the length of stay in ICU,and have a good clinical effect.

Xuebijing InjectionMeropenemSevere pulmonary infectionInflammation levelsBlood gas function

齐正勇

展开 >

顺德新容奇医院有限公司,广东佛山 528300

血必净注射液 美罗培南 重症肺感染 炎症水平 血气功能

2023

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2023.21(12)
  • 15